Thrasos Therapeutics

closed

Discovers and develops targeted therapies for the prevention and treatment of severe organ failures.

HQ location

Montreal, Canada

Website

Launch date

2002

Employees

Enterprise value

$84—126m

https://www.linkedin.com/company/thrasos-limited

biotechnology

Get premium to view all results

Date	Investors	Amount	Round
Oct 2012	investor investor investor investor investor investor investor	€0.0	round
Mar 2015	BDC Capital SR One Pappas Capital MP Healthcare Venture Management Advanced Technology Ventures Fonds de solidarité FTQ Lumira Ventures Business Development Bank of Canada (BDC)	$21.0m	Series D
Total Funding		000k

Unlock the full power of analytics with a premium account

Track company size and historic growth

Track team composition and strength

Track website visits and app downloads

Tech stackLearn more about the technologies and tools that this company uses.